
Novavax Inc
NASDAQ:NVAX

Intrinsic Value
The intrinsic value of one
NVAX
stock under the Base Case scenario is
6.13
USD.
Compared to the current market price of 6.41 USD,
Novavax Inc
is
Overvalued by 4%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Novavax Inc
Fundamental Analysis

Revenue & Expenses Breakdown
Novavax Inc
Balance Sheet Decomposition
Novavax Inc
Current Assets | 1.1B |
Cash & Short-Term Investments | 923.1m |
Receivables | 108.3m |
Other Current Assets | 97.5m |
Non-Current Assets | 431.5m |
PP&E | 300m |
Intangibles | 107.5m |
Other Non-Current Assets | 24m |
Free Cash Flow Analysis
Novavax Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Novavax Inc
Revenue
|
682.2m
USD
|
Cost of Revenue
|
-201.7m
USD
|
Gross Profit
|
480.4m
USD
|
Operating Expenses
|
-712.4m
USD
|
Operating Income
|
-231.9m
USD
|
Other Expenses
|
44.4m
USD
|
Net Income
|
-187.5m
USD
|
NVAX Profitability Score
Profitability Due Diligence
Novavax Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Score
Novavax Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.
NVAX Solvency Score
Solvency Due Diligence
Novavax Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Score
Novavax Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NVAX Price Targets Summary
Novavax Inc
According to Wall Street analysts, the average 1-year price target for
NVAX
is 17.68 USD
with a low forecast of 9.09 USD and a high forecast of 26.25 USD.
Dividends
Current shareholder yield for NVAX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
NVAX
stock under the Base Case scenario is
6.13
USD.
Compared to the current market price of 6.41 USD,
Novavax Inc
is
Overvalued by 4%.